Drug & Alcohol Rehab Centers in Maryland

Maryland's addiction treatment system is coordinated by the Behavioral Health Administration (BHA) within the Maryland Department of Health (MDH). BHA licenses providers, administers state and federal funding, operates the statewide crisis system, and manages Maryland's 211 Press 1 crisis hotline. The agency works with local addiction authorities (LAAs) in each jurisdiction to ensure treatment access across the state's diverse geography — from the densely urban Baltimore corridor to the rural Eastern Shore and Western Maryland mountains.

Key statistics:

• Approximately 2,900 drug overdose deaths in 2022 (Maryland Department of Health)
• About 600 licensed treatment facilities statewide (SAMHSA N-SSATS)
• Fentanyl involved in over 90% of opioid-related overdose deaths
• Baltimore City's overdose death rate is among the highest of any major U.S. city

The Baltimore opioid crisis has defined Maryland's treatment landscape for decades. Baltimore's heroin epidemic dates to the 1960s, and the city's entrenched open-air drug markets facilitated a rapid transition to fentanyl beginning around 2015. Baltimore City alone accounts for roughly one-third of Maryland's overdose deaths, despite having less than 10% of the state's population. The HOPE Act (Heroin and Opioid Prevention Effort), signed into law in 2017, was landmark legislation that required hospital emergency departments to screen patients for substance use disorders, established crisis treatment centers, expanded naloxone access, and increased funding for treatment and recovery services statewide.

Regional treatment patterns vary across Maryland. Baltimore and the central corridor have the highest density of treatment providers, including Johns Hopkins' world-renowned addiction research and clinical programs and the University of Maryland Medical System's behavioral health network. The Washington, D.C., suburbs of Montgomery and Prince George's counties have growing treatment infrastructure serving diverse communities. The Eastern Shore faces elevated opioid and methamphetamine use with fewer treatment options and greater reliance on telehealth. Western Maryland (Allegany, Garrett, Washington counties) contends with Appalachian-pattern opioid use. Maryland's treatment system increasingly emphasizes co-occurring mental health disorders, harm reduction, and low-barrier access to MAT.

Maryland offers the full ASAM continuum of addiction care through its licensed treatment network:

• Medical Detoxification: Hospital-based and standalone withdrawal management programs in Baltimore, the D.C. suburbs, Annapolis, Frederick, and other regions. Johns Hopkins Hospital and the University of Maryland Medical Center operate medically managed detox for complex cases. Maryland's HOPE Act crisis treatment centers also provide stabilization and detox services.
• Residential Treatment: Programs from 30 to 90+ days across the state, including clinical programs in the Baltimore metro, retreat-style facilities in rural Maryland, and long-term therapeutic communities. Maryland licenses both short-term and long-term residential providers under BHA regulations.
• Partial Hospitalization (PHP): Structured day programs available in Baltimore, the D.C. suburbs, and other metro areas, offering 5-7 days per week of intensive clinical treatment.
• Intensive Outpatient (IOP): Flexible 3-5 day per week programs widely available across Maryland. IOP is among the most commonly utilized levels of care in the state, allowing clients to maintain work and family responsibilities during recovery.
• Standard Outpatient: Weekly individual and group therapy through community behavioral health centers, private practices, and federally qualified health centers statewide.
• Telehealth Services: Maryland permanently expanded telehealth coverage for addiction treatment. Telehealth is essential for serving the Eastern Shore and Western Maryland, where in-person treatment options are limited.

Maryland is nationally recognized for its leadership in medication-assisted treatment and harm reduction. Johns Hopkins and the University of Maryland have conducted groundbreaking research on buprenorphine, methadone, and other pharmacotherapies for opioid use disorder. Baltimore's needle exchange program, established in 1994, was one of the first in the nation. 12-step programs, SMART Recovery, and other mutual aid groups are widely available. Many facilities integrate CBT, trauma-informed care, and MAT into comprehensive treatment plans.